Top Markets
Coin of the day
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

8049
Rangering i aksjer #19272
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the... Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Aksjekurs
$0.29998701
Markedsverdi
$168.04M
Endring (1 dag)
0.21%
Endring (1 år)
10.81%
Land
CN
Handel Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)

Kategori

Antall utestående aksjer for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049)
Antall utestående aksjer per August 2026: 0
Ifølge Jilin Province Huinan Changlong Bio-pharmacy Company Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter